Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,231 | -10,223 | -7,607 | -5,111 | -2,945 |
| Depreciation Amortization | 14 | 77 | 60 | 41 | 21 |
| Accounts payable and accrued liabilities | -882 | 878 | -63 | 350 | 174 |
| Other Working Capital | -1,002 | 1,066 | 341 | 212 | 313 |
| Other Operating Activity | 1,176 | 885 | 1,534 | 736 | 465 |
| Operating Cash Flow | $-2,925 | $-7,317 | $-5,735 | $-3,772 | $-1,972 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,000 | -5,500 | -8,000 | -8,000 | N/A |
| PPE Investments | N/A | -57 | -39 | -39 | -8 |
| Investing Cash Flow | $2,000 | $-5,557 | $-8,039 | $-8,039 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 9,495 | 9,313 | 9,301 | 64 |
| Financing Cash Flow | $N/A | $9,495 | $9,313 | $9,301 | $64 |
| Beginning Cash Position | 5,167 | 8,496 | 8,496 | 8,496 | 8,496 |
| End Cash Position | 4,242 | 5,117 | 4,035 | 5,986 | 6,580 |
| Net Cash Flow | $-925 | $-3,379 | $-4,461 | $-2,510 | $-1,916 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,925 | -7,317 | -5,735 | -3,772 | -1,972 |
| Capital Expenditure | N/A | -57 | -39 | -39 | -8 |
| Free Cash Flow | -2,925 | -7,374 | -5,774 | -3,811 | -1,980 |